Previous studies have explored whether soluble programmed cell death ligand-1 (sPD-L1) can be used to predict the prognosis of patients with peripheral T-cell lymphoma (PTCL); however, no consistent results have been obtained. This evidence concerns the gene SPDL1 and mature T-cell and NK-cell non-Hodgkin lymphoma.